SCREENER COMPARE ANY 2 STOCKS

EARNINGS CALL ARCHIVE 1 CALL ON FILE

BOLT — Bolt Biotherapeutics, Inc.

NASDAQ

FULL STOCK PAGE →

Q1 2024 Earnings Call Summary

MAY 17, 2024

REVENUE

$5.3M +152.5%

NET MARGIN

-205.0% +652.0 PTS

EPS

-$0.28 +40.4%

FREE CASH FLOW

-$16.8M -17.4%

No summary has been written for this call yet.